Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits anti-tumor immunity. Nature Immunology 2018; 19:723

科学

致力于研究对抗癌症、感染性疾病和自身免疫疾病的创新免疫疗法

科学

Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits anti-tumor immunity. Nature Immunology 2018; 19:723–732

2018-06-18

分享至：

法律声明隐私政策使用条款